Medical Devices - Little Rock, Arkansas, United States
RespiDerm Corporation® is researching, developing, and commercializing AirJector® Transdermal Medical Gas Delivery System and treatment method to health care service providers to treat and prevent life-threatening conditions. RespiDerm® continues with the research and development of innovative and user friendly non-invasive transdermal drug delivery solutions to improve quality of life. The mission is to determine best methods of combining the non-toxic health benefits of gaseous drugs with non-invasive transdermal delivery approaches to trigger natural responsive physiological processes in the human body that enhance the body's self-healing capabilities.
Facebook Custom Audiences
Outlook
Amadesa
Typekit
Microsoft Office 365
Amazon AWS